Aging with muscular dystrophy: pathophysiology and clinical management.
Major advances in the fields of medical science and physiology, molecular genetics, biomedical engineering, and computer science have provided individuals with muscular dystrophy (MD) with more functional equipment, allowing better strategies for improvement of quality of life. These advances have also allowed a significant number of these patients to live much longer. As progress continues to change management, it also changes patients' expectations. A comprehensive medical and rehabilitative approach to management of aging MD patients can often fulfill expectations and help them enjoy an enhanced quality of life.
Carter
Gregory T
GT
Department of Rehabilitation Medicine, University of Washington School of Medicine, Box 356490, Seattle, WA 98195, USA. gtcarter@uw.edu <gtcarter@uw.edu>
Weiss
Michael D
MD
Chamberlain
Joel R
JR
Han
Jay J
JJ
Abresch
Richard T
RT
Miró
Jordi
J
Jensen
Mark P
MP
D000203:Activities of Daily Living; D000222:Adaptation, Physiological; D000293:Adolescent; D000328:Adult; D000375:Aging / Q000502:physiology*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D004185:Disability Evaluation; D006233:Persons with Disabilities; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009136:Muscular Dystrophies / Q000401:mortality / Q000503:physiopathology* / Q000628:therapy*; D011379:Prognosis; D011788:Quality of Life; D018570:Risk Assessment; D012720:Severity of Illness Index; D018434:Sickness Impact Profile; D016019:Survival Analysis; D016896:Treatment Outcome; D055815:Young Adult